[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369002-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369002-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nucleotide-substitution-biases-in-related-cancer-driver-genes","Nucleotide Substitution Biases in Related Cancer Driver Genes","","Nucleotide substitutions are widespread in cancer cells, occurring in coding sequences and in non-coding regions such as 5′/3′ UTRs and introns. While non-coding changes may influence gene expression, coding alterations most strongly affect protein function and cellular transformation. This study analyzes substitution signatures within coding regions of the top 25 frequently mutated genes across multiple human cancers to test whether cancers show distinct substitution biases. Results show a global guanine bias toward G→A transitions, per-cancer gene-specific biases, and driver-associated altered signatures.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nucleotide-substitution-biases-in-related-cancer-driver-genes/369002/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nucleotide-substitution-biases-in-related-cancer-driver-genes/369002.png","ImageObject",300,407,{"name":42,"@type":43},"dhado","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Where do nucleotide substitutions in cancer cells occur, and which regions matter most here?","Question",{"text":63,"@type":64},"Nucleotide substitutions occur in coding regions and non-coding regions including 5′/3′ UTRs and introns. The study emphasizes that coding-region alterations most drastically affect protein function and cellular transformation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What overarching nucleotide substitution bias did the pancancer analysis find?",{"text":68,"@type":64},"The pancancer analysis found that guanine is the most altered nucleotide, with a bias toward G→A transitions.",{"name":70,"@type":61,"acceptedAnswer":71},"How can nucleotide substitution patterns help distinguish cancers?",{"text":72,"@type":64},"The analysis indicates that most cancers cluster together due to similar nucleotide changes, but certain cancers (notably lung, pancreas, and blood) can be differentiated based on specific nucleotide signatures.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369002,1790240804,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Article  \nNucleotide Substitution Biases in Related Cancer Driver Genes  \nAdam Khadre 1, Yifan Dou 1, Golrokh C. Mirzaei 1,* and Ruben C. Petreaca 2,3, *  \nAcademic Editor: Yoshihito Kano  \nReceived: 14 October 2025  \nRevised: 1 December 2025  \nAccepted: 6 December 2025  \nPublished: 10 December 2025  \nCitation: Khadre, A.; Dou, Y.; Mirzaei, G.C.; Petreaca, R.C. Nucleotide Substitution Biases in Related Cancer Driver Genes. Int. J. Mol. Sci. 2025, 26, 11903. [https://](https://)[ ](https://)[doi.org/10.3390/ijms262411903](doi.org/10.3390/ijms262411903)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Computer Science and Engineering, The Ohio State University, Columbus, OH 43210, USA; [khadre.3@buckeyemail.osu.edu](khadre.3@buckeyemail.osu.edu) (A.K.); [dou.81@buckeyemail.osu.edu](dou.81@buckeyemail.osu.edu) (Y.D.)  \n2 Department of Molecular Genetics, The Ohio State University, Marion, OH 43302, USA  \n3 The Ohio State University James Comprehensive Cancer Center, Columbus, OH 43210, USA  \n* [Correspondence: mirzaei.4@osu.edu](Correspondence: mirzaei.4@osu.edu) (G.C.M.); [petreaca.1@osu.edu](petreaca.1@osu.edu) (R.C.P.)  \nAbstract  \nNucleotide substitutions are common in cancer cells, and they occur in both protein coding regions and non-coding regions (5′ and 3′ UTRs and introns) . Although substitutionsin non-coding regions have the potential to alter gene expression, it is the alteration of coding regions that affects protein function and has the most drastic effect on cellular transformation. Mutations in certain genes (e.g., TP53, KRAS) are common to nearly all cancers, but most cancers are characterized by specific gene mutation signatures. In this report, we investigated nucleotide substitution signatures in coding regions of the top 25 most frequently mutated genes in multiple human cancers. The goal was to examine whether unique nucleotide substitution biases are associated with various cancers. A pancancer analysis showed that the most altered nucleotide is guanine, which is biased towards G->A transitions. A per-cancer analysis identified ten cancers with biased substitutions in certain genes. Some of these biases were expected (e.g., KRAS in gastrointestinal cancers or JAK2 in blood cancers) . Our analysis revealed biased signature substitutions in 17 genes, of which 14 were characterized as drivers and constituted a closely related set of cell cycle regulators. We conclude that nucleotide substitution biases contribute to specific alterationsin cancer genes that produce cellular transformation. Principle component analysis of nucleotide substitutions shows that most cancers cluster together, meaning that they have similar nucleotide changes. However, certain cancers, most notably lung, pancreas, and blood cancers, can be differentiated from each other based on specific nucleotide signatures. Thus, nucleotide substitution patterns can be used to differentiate between some cancers.  \nKeywords: mutation bias; nucleotide substitution; purifying selection; cancer  \n1. Introduction  \nMutation is the primary driver of genetic alteration that produces both evolutionary change and cellular transformation which causes cancer [1,2] . Mutations can be generated by endogenous processes such as DNA replication or may be caused by exogeneous factors like mutagens and carcinogens. Recent comprehensive analyses of cancer genomes have shown that endogenous and exogeneous factors can cause distinct patterns of mutation signatures [3–8] . Although many forms of genomic alterations are observed in cancer cells (e.g., nucleotide substitutions, deletions, insertions, translocations, and other chromosomal re-arrangements),","cbCaihoZx6NhcHBm","https://ap.wps.com/l/cbCaihoZx6NhcHBm","pdf",2911184,15,"English","# Introduction\n## Mutation signatures and sources\n## Coding vs non-coding substitution effects\n## Driver and passenger genes\n## Mutation hotspots and purifying selection\n## Cancer-specific gene mutation programs","[{\"question\":\"Where do nucleotide substitutions in cancer cells occur, and which regions matter most here?\",\"answer\":\"Nucleotide substitutions occur in coding regions and non-coding regions including 5′/3′ UTRs and introns. The study emphasizes that coding-region alterations most drastically affect protein function and cellular transformation.\"},{\"question\":\"What overarching nucleotide substitution bias did the pancancer analysis find?\",\"answer\":\"The pancancer analysis found that guanine is the most altered nucleotide, with a bias toward G→A transitions.\"},{\"question\":\"How can nucleotide substitution patterns help distinguish cancers?\",\"answer\":\"The analysis indicates that most cancers cluster together due to similar nucleotide changes, but certain cancers (notably lung, pancreas, and blood) can be differentiated based on specific nucleotide signatures.\"}]","Nucleotide Substitution Biases in Related Cancer Driver Genes | PDF",1790180114,38,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64606d15ab6b4e2ff7cfd1c5e4af077e.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3221b04185431b2989249b353fa52ef4.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7cb1851cdfc1e28ad4ac9380d4e1b74.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1cd5aba842977de477a9db9d4b4b97b4.webp",980,1385]